The U.S. Food and Drug Administration said on Monday it will not take action against compounding pharmacies making copies of ...

If drug tariffs don’t work, they could result in higher prices for American patients and increase drug shortages. Testing ...

The Boston-based company's new medication, called Journavx, is being placed on a tier that means it might be costlier than ...

Teva's business is encountering headwinds, including declining U.S. generics revenue. Read what this biotech plans to do in ...

Mankind Pharma, Alkem Laboratories, Glenmark are some of the companies to have launched, making the drug affordable to most ...

To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...

Alkem Laboratories has launched a generic medication for type-2 diabetes, chronic kidney disease and heart failure in India ...

Hint: It's all in the suffix. Viagra, Prozac, Xanax, and Zoloft all went through a process to select memorable names.

Hikma launched liraglutide, a generic version of an earlier Novo Nordisk weight loss drug, in the US in December. Liraglutide, which Novo sells as Victoza for diabetes and Saxenda for weight loss, has ...

Mankind Pharma and other domestic companies have launched generic versions of the popular diabetes drug Empagliflozin at ...

Four companies have applied to Health Canada to sell copies of Ozempic after its market exclusivity expires on Jan. 4, 2026 ...

Novo Nordisk’s semaglutide diabetes and weight loss drugs, Ozempic and Wegovy, are no longer officially in shortage in the US ...